GlassScriptPhysician profile
Subhas Gupta
NPI 1659309805
$178,119.79
in general payments reported to CMS, 2019-2025
36 companies · $94K in 2025
The $94K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,607 · 2020: $12K · 2021: $10K · 2022: $12K · 2023: $7,437 · 2024: $33K · 2025: $94K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $97K · Travel and Lodging: $29K · Food and Beverage: $5,658 · Debt Forgiveness: $3,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $96,500.00 |
| Travel and Lodging | $29,303.32 |
| Food and Beverage | $5,657.61 |
| Debt Forgiveness | $3,078.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $162,347.44 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $3,685.90 | 2023-2025 | |
| Johnson & Johnson Health Care Systems INC. | $3,078.00 | 2024 | |
| Kci USA, INC. | $3,007.27 | 2019-2023 | Prevena, V.A.C.Ulta, V.A.C. Dermatac |
| Musculoskeletal Transplant Foundation INC. | $1,554.24 | 2020-2025 | |
| Solventum Corporation | $1,269.36 | 2024-2025 | Prevena, V.A.C. Veraflo, Abthera |
| Mentor Worldwide LLC | $445.89 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Innovation Technologies INC | $418.28 | 2022-2024 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $378.90 | 2024-2025 | |
| Motiva USA, LLC | $327.89 | 2024-2025 | |
| Axogen | $225.07 | 2019-2025 | |
| Lifenet Health | $171.42 | 2024 | Theragenesis Wound Matrix |
| Rti Surgical, INC | $146.23 | 2024 | |
| Tela Bio, INC. | $135.15 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Wright Medical Technology, INC. | $134.65 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $121.30 | 2019-2020 | |
| Acelrx Pharmaceuticals, INC. | $85.02 | 2021 | |
| Allergan, INC. | $73.58 | 2019-2022 | |
| Checkpoint Surgical, INC | $73.24 | 2021-2023 | Checkpoint Stimulators |
| Aroa Biosurgery Incorporated | $58.75 | 2022 | |
| Kls-Martin L.P. | $52.62 | 2025 | |
| Mimedx Group, INC. | $46.35 | 2025 | |
| Medline Industries LP | $45.24 | 2019 | |
| Smith+Nephew, INC. | $44.18 | 2020 | |
| Mesh Suture INC | $30.78 | 2023 | |
| Novo Nordisk INC | $24.96 | 2024 | |
| Heron Therapeutics, INC. | $23.11 | 2023 | Aponvie |
| Bioventus LLC | $20.42 | 2022 | |
| Boston Scientific Corporation | $16.90 | 2021 | |
| Baxter Healthcare | $16.45 | 2021 | |
| Coopersurgical, INC. | $15.59 | 2025 | Insorb |
| Zimmer Biomet Holdings, INC. | $15.18 | 2020 | |
| Stryker Corporation | $14.91 | 2022 | |
| Medela LLC | $8.64 | 2020 | |
| Apyx Medical Corporation | $6.88 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subhas Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.